The Emerging Medical Innovation Valuation Competition is for researchers and inventors to get immediate feedback about their projects from leaders in the fields of medical technology research, engineering & development*. This competition is for inventors (including students, faculty, staff, and corporations) with ideas for new innovations needing investor support to reach the next stage of development.
Initial submissions should be no more than 10 slides summarizing the innovation.
Judges will review all the submissions and finalists will be invited to compete in-person during the DMD Conference.
After the in-person presentations, the judges will determine the top three innovations with the greatest return on investment and investment potential. Winners will be announced during the DMD Keynote Lunch immediately following the competition.
Judges will base their decision on four questions:
- Can the technology be built and scaled to production?
- Are the intellectual property and regulatory approach reasonable?
- Is a viable reimbursement strategy possible?
- What is the potential and timing for return on investment?
The top three inventors will be awarded a full valuation, including presentation and report from the University of Minnesota’s Medical Valuation Laboratory.
This competition is presented by
